93 related articles for article (PubMed ID: 6330589)
1. Mechanisms of converting enzyme inhibition: studies in experimental animals.
Dinicolantonio R; Mendelsohn FA; Takata Y; Hutchinson JS; Doyle AE
Neth J Med; 1984; 27(4):153-60. PubMed ID: 6330589
[No Abstract] [Full Text] [Related]
2. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats.
Takata Y; Di Nicolantonio R; Hutchinson JS
Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035
[TBL] [Abstract][Full Text] [Related]
3. [Effects of 3 different angiotensin converting enzyme inhibitors, MK 421, SQ 14225 and SA 446 on renal function and blood pressure in patients with essential hypertension].
Tajima J; Abe K; Yasujima M; Tanno M; Yoshinaga K
Nihon Jinzo Gakkai Shi; 1984 Jun; 26(6):779-89. PubMed ID: 6096607
[No Abstract] [Full Text] [Related]
4. A comparison of the activity of the angiotensin converting enzyme inhibitors SQ 14 225, SA 446, and MK 421.
Takata Y; Di Nicolantonio R; Mendelsohn FA; Hutchinson JS; Doyle AE
Clin Exp Pharmacol Physiol; 1983; 10(2):131-45. PubMed ID: 6307563
[No Abstract] [Full Text] [Related]
5. Effects of converting enzyme inhibitors on renin-angiotensin system in normal rats.
Komori T; Takada T; Funae Y; Yamamoto K
Osaka City Med J; 1984 Jun; 30(1):17-30. PubMed ID: 6096787
[No Abstract] [Full Text] [Related]
6. In vivo comparison of three orally active inhibitors of angiotensin-converting enzyme.
DiNicolantonio R; Dinicolantonio R; Hutchinson JS; Mendelsohn FA; Doyle AE
Am J Cardiol; 1982 Apr; 49(6):1502-4. PubMed ID: 6280478
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the acute effects of three structurally different converting enzyme inhibitors (captopril, SA-446 and MK-421) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system.
Kondo K; Kida O; Kodama K; Higa T; Someya N; Morotomi Y; Tanaka K
Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):337-42. PubMed ID: 2991635
[No Abstract] [Full Text] [Related]
8. Effects of sodium loading on antihypertensive responses to an angiotensin-converting enzyme inhibitor in spontaneously hypertensive and renal hypertensive rats.
Nakata K; Takada T; Yamauchi H; Iso T
Eur J Pharmacol; 1986 Feb; 121(2):293-5. PubMed ID: 3009208
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421.
Cohen ML; Kurz KD
J Pharmacol Exp Ther; 1982 Jan; 220(1):63-9. PubMed ID: 6273529
[No Abstract] [Full Text] [Related]
10. Renal kallikrein-kinin system and the depressor effect of angiotensin converting enzyme inhibitors MK 421, SA 446, and captopril in rats.
Yasujima M; Abe K; Kasai Y; Tanno M; Tajima J; Seino M; Chiba S; Sato K; Goto T; Omata K
Clin Exp Hypertens A; 1984; 6(6):1207-25. PubMed ID: 6086184
[TBL] [Abstract][Full Text] [Related]
11. Responses of the kallikrein-kinin system to angiotensin converting enzyme inhibitors in the rat.
Yasujima M; Abe K; Tanno M; Omata K; Yoshinaga K
Jpn Circ J; 1984 Feb; 48(2):173-9. PubMed ID: 6321815
[TBL] [Abstract][Full Text] [Related]
12. Effects of angiotensin I converting enzyme inhibitors on the renal excretory function, hemodynamics and renin release in isolated perfused rat kidney.
Ogihara T; Yoshizawa M; Yasui T; Nakane H; Nakane Y; Saruta T
Jpn Heart J; 1983 Nov; 24(6):975-83. PubMed ID: 6323782
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive mechanism of an angiotensin converting enzyme inhibitor, SA446, in dogs.
Nishimura K; Okunishi H; Miyazaki M
Bull Osaka Med Coll; 1989 Nov; 35(1-2):29-37. PubMed ID: 2486241
[TBL] [Abstract][Full Text] [Related]
14. Effects of angiotensin converting enzyme inhibitor (SA-446) on regional hemodynamics in renal and spontaneously hypertensive rats.
Abe Y; Sakamoto W; Fukui K; Iwao H; Takada T; Yamamoto K
Arch Int Pharmacodyn Ther; 1988; 292():237-47. PubMed ID: 3395170
[TBL] [Abstract][Full Text] [Related]
15. Effects of angiotensin converting enzyme inhibitors MK 421, SA 446 and captopril on renal prostaglandin E and kinins in conscious normotensive rats.
Yasujima M; Abe K; Tanno M; Kohzuki M; Kasai Y; Kanazawa M; Omata K; Sato M; Takeuchi K; Yoshinaga K
Clin Exp Hypertens A; 1987; 9(2-3):401-4. PubMed ID: 3038402
[TBL] [Abstract][Full Text] [Related]
16. Complex competitive and non-competitive inhibition of rat lung angiotensin-converting enzyme by inhibitors containing thiol groups: captopril and SA 446.
Mendelsohn FA; Csicsmann J; Hutchinson JS
Clin Sci (Lond); 1981 Dec; 61 Suppl 7():277s-280s. PubMed ID: 6172236
[TBL] [Abstract][Full Text] [Related]
17. [Effect of enalapril on cerebral circulation and its autoregulation in hypertensive rats].
Adzhienko LM; Asiedu DI
Biull Eksp Biol Med; 1999 Jun; 127(6):642-4. PubMed ID: 10445129
[No Abstract] [Full Text] [Related]
18. SA446, a new orally active converting enzyme inhibitor: antihypertensive action and comparison with captopril in stroke-prone spontaneously hypersensitive rats.
Unger T; Yukimura T; Marin-Grez M; Lang RE; Rascher W; Ganten D
Eur J Pharmacol; 1982 Mar; 78(4):411-20. PubMed ID: 6281036
[TBL] [Abstract][Full Text] [Related]
19. Effects of three different kininase II inhibitors on blood pressure and renal vasoactive substances in essential hypertensives.
Abe K; Tajima J; Omata K; Tanno M; Tsunoda K; Kudo K; Onoda Y; Kohzuki M; Sasaki S; Takeuchi K
Adv Exp Med Biol; 1986; 198 Pt B():269-77. PubMed ID: 3028076
[No Abstract] [Full Text] [Related]
20. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
Guidi E; Hollenberg NK
J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]